465 related articles for article (PubMed ID: 5140093)
21. [Results of treatment of Parkinsonism with L-dopa].
De Divitiis E; D'Andrea F; Signorelli CD
Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563
[No Abstract] [Full Text] [Related]
22. Amantadine for Parkinson's disease.
Mann DC; Pearce LA; Waterbury LD
Neurology; 1971 Sep; 21(9):958-62. PubMed ID: 4936828
[No Abstract] [Full Text] [Related]
23. [Amantadine therapy in parkinsonism].
Pakkenberg H
Ugeskr Laeger; 1973 Jan; 135(3):135-6. PubMed ID: 4685048
[No Abstract] [Full Text] [Related]
24. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Schwab RS; England AC
Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
[No Abstract] [Full Text] [Related]
25. [The treatment of Parkinson's disease with levodopa. Principles. Practical advice. Considerations].
Sigwald J
Nouv Presse Med; 1972 Mar; 1(10):679-82. PubMed ID: 5022921
[No Abstract] [Full Text] [Related]
26. [Treatment of Parkinsonian syndrome using amantadine hydrochloride].
Schubert U; Fischer GJ; Glass J
Z Arztl Fortbild (Jena); 1975 May; 69(9):469-76. PubMed ID: 1106004
[No Abstract] [Full Text] [Related]
27. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
Antonini FM; Baroni A
Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
[No Abstract] [Full Text] [Related]
28. [L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation].
Antonini F; Baroni A; Roveyaz L
Sist Nerv; 1970; 22(2):74-81. PubMed ID: 5504560
[No Abstract] [Full Text] [Related]
29. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
De la Herrán J; Figuerido JA
Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
[No Abstract] [Full Text] [Related]
30. [Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents].
Gospavić J; Vidaković Z
Srp Arh Celok Lek; 1974 Jun; 102(6):447-57. PubMed ID: 4450143
[No Abstract] [Full Text] [Related]
31. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920
[No Abstract] [Full Text] [Related]
32. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
Gerstenbrand F; Grünberger J; Oberhummer I
HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006
[No Abstract] [Full Text] [Related]
33. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
Kamianov IM; Kupisk AG; Katsen IZ
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
[No Abstract] [Full Text] [Related]
34. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
[No Abstract] [Full Text] [Related]
35. [Treatment of parkinsonism with the drug L-DOPA].
Stoliarova LG; Kistenev BA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
[No Abstract] [Full Text] [Related]
36. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
Birkmayer W; Linauer W; Mentasti M; Riederer P
Wien Med Wochenschr; 1974 Jun; 124(22):340-4. PubMed ID: 4275492
[No Abstract] [Full Text] [Related]
37. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
Fasano VA; Urciuoli R; Broggi G
Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
[No Abstract] [Full Text] [Related]
38. [Study of L-dopa treatment and its principal side effects in aged subjects].
Antonini F; Baroni A; Bucalossi A; Roveyaz L
Gerontol Clin (Basel); 1972; 14(5):297-309. PubMed ID: 4144357
[No Abstract] [Full Text] [Related]
39. [Psychologic evaluation of amantadine treatment of parkinsonism and comparative analysis of the effects with L-dopa].
Puca FM; Micalizzi V; Megna GF; Barbieri NF; Pigneri MT
Acta Neurol (Napoli); 1971; 26(6):707-30. PubMed ID: 4946491
[No Abstract] [Full Text] [Related]
40. [Treatment with L-dopa in Parkinsonian syndromes].
De Renzi E; Pieczuro A
Sist Nerv; 1970; 22(1):1-11. PubMed ID: 5502951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
